Marquette Asset Management’s Bicycle Therapeutics BCYC Stock Holding History

Marquette Asset Management’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-72,854	Closed	-$309K	–	799
2026 Q2	$309K	Buy	+72,854	New	+$334K	0.04%	71

Other funds holding BCYC

Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Marquette Asset Management's BCYC Position: Q3 2026 in Review

Marquette Asset Management sold out of Bicycle Therapeutics (BCYC) in Q3 2026, closing a stake of 72,854 shares — an estimated $309K sold.

Marquette Asset Management first reported a position in BCYC in Q2 2026 and held it in 1 quarter. The position peaked at $309K in Q2 2026. 2 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

Marquette Asset Management reported no remaining Bicycle Therapeutics position as of Q3 2026 after selling out during the quarter.
Marquette Asset Management sold 72,854 Bicycle Therapeutics shares in Q3 2026, an estimated $309K.
Marquette Asset Management first reported a position in Bicycle Therapeutics in Q2 2026 and held it in 1 quarter.
Marquette Asset Management's Bicycle Therapeutics position peaked at $309K in Q2 2026.
2 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.